Access government grants and external funding
Grants and funding opportunities to build your research project.
We look for opportunities to help you secure funding through government grants and other funding programs that offer incentives to universities to build collaborative research projects. To kick start the process, contact the Business Development Manager in your faculty or the Monash Research Office directly for assistance with grant applications.
Funding programs
Find MRO funding opportunities
Other funding opportunities
The Monash Research Impact Fund (MRIF) is designed to support research initiatives that have the potential to create significant societal impact. It is particularly aimed at projects that align with Monash University's strategic goals in research and innovation. Researchers, academic staff, and teams looking to translate their findings into real-world applications may find this fund beneficial.
The Medical Research Future Fund (MRFF) is an investment fund established to support health and medical research in Australia. It provides around $650 million annually for research aimed at improving health outcomes. This opportunity is ideal for medical researchers, healthcare professionals, and organisations focused on innovative health solutions and therapies that address pressing health challenges in Australia.
Australia's Economic Accelerator (AEA) aims to enhance the translation of research into commercial outcomes by providing funding to researchers, entrepreneurs, and businesses. It focuses on priority sectors such as space, medical products, and clean energy. This program is suitable for researchers, startups, and established businesses looking to develop innovative solutions that contribute to Australia's economic growth and sustainability.
The Medical Research Commercialisation Initiative is a $450 million program aimed at advancing health and medical research in Australia from 2024 to 2034. Building on previous initiatives, like BioMedTech Horizons and the Biomedical Translation Bridge, this initiative fosters innovation and entrepreneurship, helping researchers transform discoveries into viable medical products.
Therapeutic Innovation Australia (TIA) focuses on enhancing the translation of research discoveries into therapeutic solutions. It supports various capabilities, including biologics, vaccines, and gene therapies. Researchers involved in drug development, or those looking to scale their innovations, will find TIA's resources and infrastructure particularly advantageous.
The National Foundation for Medical Research and Innovation (NFMRI), funds innovative biomedical research projects aimed at preventing or eradicating diseases. Its focus is on advancing ideas that can lead to viable healthcare products. Researchers working on groundbreaking treatments or technologies that improve public health may benefit from this funding opportunity.
The CSL Research Acceleration Initiative (RAI) is designed to fast-track the discovery of innovative biotherapies through partnerships with global research organisations. Offering up to USD $400,000 over two years, this initiative targets early-stage projects in biotherapeutics. Scientists looking for industry collaboration and funding support for novel therapeutic strategies should consider applying.
Takeda's COCKPI-T program invites applications from researchers focusing on early-stage projects in neuroscience, oncology, gastroenterology, and platform technologies. This program aims to catalyse innovative therapeutics development. It is suitable for researchers affiliated with universities or research institutes who are exploring new therapeutic avenues.